
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc. is positioned to capitalize on a favorable 2026 Medicare Advantage (MA) rate update, particularly as many managed care organizations (MCOs) are reducing benefits, giving ALHC a competitive advantage through its Stars funding. The company's integrated MA-Value-Based Care (VBC) model is anticipated to support long-term market share gains and foster above-average growth. Additionally, the projected gross profit per member per month (PMPM) for early cohorts is expected to increase significantly over time, with estimates ranging from $90-$150 initially, potentially reaching over $230 PMPM by years 3-5, indicating a robust financial trajectory.
Bears say
Alignment Healthcare has demonstrated a notable ability to reduce Average Daily Census (ADK) during a period characterized by increased healthcare utilization, suggesting underlying operational strengths; however, this does not fully mitigate potential concerns. Despite achieving above-average EBITDA growth and a valuation multiple that is somewhat elevated compared to peer Medicare Managed Care Organizations (MCOs), persistent challenges related to data friction among payors and inconsistency in results from affiliated primary care providers signal operational vulnerabilities. Consequently, the underlying issues present in its value-based care (VBC) model may undermine the long-term financial stability of Alignment Healthcare, contributing to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares